{"id":"https://openalex.org/W2160161908","doi":"https://doi.org/10.1158/0008-5472.sabcs10-pd01-03","title":"Abstract PD01-03: Review of Capecitabine for the Treatment of Triple-Negative Early Breast Cancer","display_name":"Abstract PD01-03: Review of Capecitabine for the Treatment of Triple-Negative Early Breast Cancer","publication_year":2010,"publication_date":"2010-12-01","ids":{"openalex":"https://openalex.org/W2160161908","doi":"https://doi.org/10.1158/0008-5472.sabcs10-pd01-03","mag":"2160161908"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.sabcs10-pd01-03","doi":"https://doi.org/10.1158/0008-5472.sabcs10-pd01-03","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs10-pd01-03","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111802516","display_name":"G.G. Steger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]},{"id":"https://openalex.org/I4210137261","display_name":"Hospital S\u00e3o Lucas da PUCRS","ror":"https://ror.org/0353n6963","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210137261"]},{"id":"https://openalex.org/I45643870","display_name":"Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul","ror":"https://ror.org/025vmq686","country_code":"BR","type":"education","lineage":["https://openalex.org/I45643870"]},{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT","BR","ES"],"is_corresponding":false,"raw_author_name":"GG Steger","raw_affiliation_strings":["Medical University of Vienna, Austria; Hospital Sao Lucas da PUCRS, Oncology, Porto Alegre, Brazil; US Oncology, Dallas, TX; Hospital Universitario San Carlos, Madrid, Spain","Hospital Universitario San Carlos, Madrid, Spain","Medical University of Vienna, Austria","US Oncology, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Vienna, Austria; Hospital Sao Lucas da PUCRS, Oncology, Porto Alegre, Brazil; US Oncology, Dallas, TX; Hospital Universitario San Carlos, Madrid, Spain","institution_ids":["https://openalex.org/I4210137261","https://openalex.org/I45643870","https://openalex.org/I76134821"]},{"raw_affiliation_string":"Hospital Universitario San Carlos, Madrid, Spain","institution_ids":["https://openalex.org/I2961216182"]},{"raw_affiliation_string":"Medical University of Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]},{"raw_affiliation_string":"US Oncology, Dallas, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112256215","display_name":"C.H. Barrios","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]},{"id":"https://openalex.org/I4210137261","display_name":"Hospital S\u00e3o Lucas da PUCRS","ror":"https://ror.org/0353n6963","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210137261"]},{"id":"https://openalex.org/I45643870","display_name":"Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul","ror":"https://ror.org/025vmq686","country_code":"BR","type":"education","lineage":["https://openalex.org/I45643870"]},{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT","BR","ES"],"is_corresponding":false,"raw_author_name":"C Barrios","raw_affiliation_strings":["Medical University of Vienna, Austria; Hospital Sao Lucas da PUCRS, Oncology, Porto Alegre, Brazil; US Oncology, Dallas, TX; Hospital Universitario San Carlos, Madrid, Spain","Hospital Universitario San Carlos, Madrid, Spain","Medical University of Vienna, Austria","US Oncology, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Vienna, Austria; Hospital Sao Lucas da PUCRS, Oncology, Porto Alegre, Brazil; US Oncology, Dallas, TX; Hospital Universitario San Carlos, Madrid, Spain","institution_ids":["https://openalex.org/I4210137261","https://openalex.org/I45643870","https://openalex.org/I76134821"]},{"raw_affiliation_string":"Hospital Universitario San Carlos, Madrid, Spain","institution_ids":["https://openalex.org/I2961216182"]},{"raw_affiliation_string":"Medical University of Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]},{"raw_affiliation_string":"US Oncology, Dallas, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071432873","display_name":"Joyce O\u2019Shaughnessy","orcid":"https://orcid.org/0000-0002-2955-5523","observed_orcids":["https://orcid.org/0000-0002-2955-5523","https://orcid.org/0000-0001-6764-2807"]},"institutions":[{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]},{"id":"https://openalex.org/I4210137261","display_name":"Hospital S\u00e3o Lucas da PUCRS","ror":"https://ror.org/0353n6963","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210137261"]},{"id":"https://openalex.org/I45643870","display_name":"Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul","ror":"https://ror.org/025vmq686","country_code":"BR","type":"education","lineage":["https://openalex.org/I45643870"]},{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT","BR","ES"],"is_corresponding":false,"raw_author_name":"J O'Shaughnessy","raw_affiliation_strings":["Medical University of Vienna, Austria; Hospital Sao Lucas da PUCRS, Oncology, Porto Alegre, Brazil; US Oncology, Dallas, TX; Hospital Universitario San Carlos, Madrid, Spain","Hospital Universitario San Carlos, Madrid, Spain","Medical University of Vienna, Austria","US Oncology, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Vienna, Austria; Hospital Sao Lucas da PUCRS, Oncology, Porto Alegre, Brazil; US Oncology, Dallas, TX; Hospital Universitario San Carlos, Madrid, Spain","institution_ids":["https://openalex.org/I4210137261","https://openalex.org/I45643870","https://openalex.org/I76134821"]},{"raw_affiliation_string":"Hospital Universitario San Carlos, Madrid, Spain","institution_ids":["https://openalex.org/I2961216182"]},{"raw_affiliation_string":"Medical University of Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]},{"raw_affiliation_string":"US Oncology, Dallas, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100671433","display_name":"Miguel Mart\u00edn","orcid":"https://orcid.org/0000-0001-9237-3231","observed_orcids":["https://orcid.org/0000-0001-9237-3231"]},"institutions":[{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]},{"id":"https://openalex.org/I4210137261","display_name":"Hospital S\u00e3o Lucas da PUCRS","ror":"https://ror.org/0353n6963","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210137261"]},{"id":"https://openalex.org/I45643870","display_name":"Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul","ror":"https://ror.org/025vmq686","country_code":"BR","type":"education","lineage":["https://openalex.org/I45643870"]},{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT","BR","ES"],"is_corresponding":false,"raw_author_name":"M Martin","raw_affiliation_strings":["Medical University of Vienna, Austria; Hospital Sao Lucas da PUCRS, Oncology, Porto Alegre, Brazil; US Oncology, Dallas, TX; Hospital Universitario San Carlos, Madrid, Spain","Hospital Universitario San Carlos, Madrid, Spain","Medical University of Vienna, Austria","US Oncology, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Vienna, Austria; Hospital Sao Lucas da PUCRS, Oncology, Porto Alegre, Brazil; US Oncology, Dallas, TX; Hospital Universitario San Carlos, Madrid, Spain","institution_ids":["https://openalex.org/I4210137261","https://openalex.org/I45643870","https://openalex.org/I76134821"]},{"raw_affiliation_string":"Hospital Universitario San Carlos, Madrid, Spain","institution_ids":["https://openalex.org/I2961216182"]},{"raw_affiliation_string":"Medical University of Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]},{"raw_affiliation_string":"US Oncology, Dallas, TX","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025718393","display_name":"Michael Gnant","orcid":"https://orcid.org/0000-0003-1002-2118","observed_orcids":["https://orcid.org/0000-0003-1002-2118"]},"institutions":[{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]},{"id":"https://openalex.org/I4210137261","display_name":"Hospital S\u00e3o Lucas da PUCRS","ror":"https://ror.org/0353n6963","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210137261"]},{"id":"https://openalex.org/I45643870","display_name":"Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul","ror":"https://ror.org/025vmq686","country_code":"BR","type":"education","lineage":["https://openalex.org/I45643870"]},{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT","BR","ES"],"is_corresponding":false,"raw_author_name":"M. Gnant","raw_affiliation_strings":["Medical University of Vienna, Austria; Hospital Sao Lucas da PUCRS, Oncology, Porto Alegre, Brazil; US Oncology, Dallas, TX; Hospital Universitario San Carlos, Madrid, Spain","Hospital Universitario San Carlos, Madrid, Spain","Medical University of Vienna, Austria","US Oncology, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Vienna, Austria; Hospital Sao Lucas da PUCRS, Oncology, Porto Alegre, Brazil; US Oncology, Dallas, TX; Hospital Universitario San Carlos, Madrid, Spain","institution_ids":["https://openalex.org/I4210137261","https://openalex.org/I45643870","https://openalex.org/I76134821"]},{"raw_affiliation_string":"Hospital Universitario San Carlos, Madrid, Spain","institution_ids":["https://openalex.org/I2961216182"]},{"raw_affiliation_string":"Medical University of Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]},{"raw_affiliation_string":"US Oncology, Dallas, TX","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"70","issue":"24_Supplement","first_page":"PD01","last_page":"03"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.9760000109672546},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":1.0},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":1.0},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9089999794960022},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.8149999976158142},{"id":"https://openalex.org/keywords/recurrence-free-survival","display_name":"recurrence-free survival","score":0.9610000252723694},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.7900000214576721},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.7200000286102295},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.8600000143051147},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.6919999718666077},{"id":"https://openalex.org/keywords/subgroup-heterogeneity","display_name":"subgroup heterogeneity","score":0.5180000066757202}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8797680139541626},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.8025665879249573},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.7321301102638245},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6787184476852417},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.6328540444374084},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.5947560667991638},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5787544250488281},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5659292936325073},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.557504415512085},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.5422978401184082},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5149555802345276},{"id":"https://openalex.org/C2778658803","wikidata":"https://www.wikidata.org/wiki/Q1592932","display_name":"Pegfilgrastim","level":5,"score":0.4586195647716522},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.35822784900665283},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3535007834434509},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.32113850116729736},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.261208713054657},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.20487719774246216},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.16142001748085022},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.06667214632034302}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.sabcs10-pd01-03","doi":"https://doi.org/10.1158/0008-5472.sabcs10-pd01-03","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs10-pd01-03","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.800000011920929,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4236171035","https://openalex.org/W1563397023","https://openalex.org/W1980082967","https://openalex.org/W2036450045","https://openalex.org/W2001923767","https://openalex.org/W2105417870","https://openalex.org/W2244951758","https://openalex.org/W2888280674","https://openalex.org/W1988337177","https://openalex.org/W3000295007"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Patients":[2,140,176,232,288],"with":[3,14,50,86,126,141,177,233,277,285,289,355,374,391,414,423,449,462],"triple-negative":[4],"breast":[5,32,143],"cancer":[6,33,144],"(TNBC)":[7],"have":[8],"a":[9,15,56,92,241,247,421],"high":[10,179],"unmet":[11],"therapeutic":[12],"need":[13],"generally":[16],"poor":[17],"prognosis.":[18,425],"Initial":[19,366],"data":[20,367,468],"from":[21,120,403],"two":[22,122],"randomised,":[23,379,428],"phase":[24,380,429],"III":[25,381,430],"trials":[26,382],"of":[27,53,59,89,133,245,261,394,409,456],"capecitabine":[28],"(C)":[29],"in":[30,44,81,124,135,152,184,235,275,291,323,329,349,370,386,412,447,471],"early":[31,463],"(EBC),":[34],"ABCSG-24":[35,40,154,237,376],"and":[36,165,377,388,465],"FinXX,":[37],"are":[38,372,417,469],"promising.":[39],"demonstrated":[41],"significant":[42,79,384],"improvements":[43,80,385],"pathological":[45],"complete":[46],"response":[47],"(pCR)":[48],"rate":[49],"the":[51,87,130,153,185,236,262,265,269,292,315,324,330,350,375,392,434,453],"incorporation":[52],"C":[54,90,134,172,224,351,369,395,410,441,457],"into":[55],"neoadjuvant":[57],"regimen":[58,96],"epirubicin":[60],"(E)":[61],"plus":[62],"docetaxel":[63],"(D)":[64],"(24.3%":[65],"vs":[66,98,283,306,335],"16.0%;":[67],"p=0.02)":[68],"[Steger":[69],"G,":[70],"et":[71,111],"al.":[72,112],"ECCO-ESMO":[73],"2009;":[74],"Abst":[75],"4BA].":[76],"FinXX":[77,186,293,378],"revealed":[78],"3-year":[82,318],"recurrence-free":[83],"survival":[84],"(RFS)":[85],"addition":[88,393],"to":[91,128,156,188,396,458],"sequential":[93],"taxane-anthracycline":[94],"adjuvant":[95,445],"(92.5%":[97],"88.9%":[99],"control;":[100],"hazard":[101],"ratio":[102,253],"[HR]":[103],"0.66,":[104],"95%":[105,256,310,340,361],"CI":[106,311,341],"0.47-0.94;":[107],"p=0.020)":[108],"[Joensuu":[109],"H,":[110],"Lancet":[113],"Oncol":[114],"2009].":[115],"We":[116],"review":[117],"subgroup":[118,401],"analyses":[119,402],"these":[121,404],"studies":[123,405],"patients":[125,276,301,354,413,448,461],"TNBC":[127,234,278,290,303,316,356,464],"assess":[129],"potential":[131],"benefit":[132,408],"this":[136],"patient":[137],"subgroup.":[138],"Methods:":[139],"operable":[142],"except":[145],"T4d,":[146],"\u00b1":[147,171],"nodal":[148],"involvement":[149],"were":[150,182,273],"randomised":[151,183],"study":[155,187,238,267,294,431,455],"6x":[157],"ED":[158],"every":[159,204,228],"21":[160,205,229],"days":[161],"(dl:":[162],"E":[163,198,221],"75mg/m2":[164,199,222],"D":[166,216],"75mg/m2,":[167],"d2:":[168],"pegfilgrastim":[169],"6mg)":[170],"(1,000mg/m2":[173],"b.i.d.,":[174,226],"d1-14).":[175],"medium-to":[178],"risk":[180],"EBC":[181,371],"3x":[189,208],"D\u22653x":[190],"CycEF":[191],"(D":[192],"80mg/m2":[193],"d1\u2192cyclophosphamide":[194],"[Cyc]":[195],"600mg/m2":[196,202,219],"d1,":[197,200,203,220,223],"F":[201],"days)":[206],"or":[207,357],"CD\u22653x":[209],"CycEC":[210],"(C":[211],"900mg/m2":[212,225],"bid":[213],"d1-15":[214],"+":[215],"60mg/m2":[217],"d1\u2192Cyc":[218],"d1-15,":[227],"days).":[230],"Results:":[231],"(n=122)":[239],"had":[240,296],"significantly":[242,297,321,348],"greater":[243],"chance":[244],"achieving":[246],"pCR":[248,271,387],"than":[249,300,328],"non-TNBC":[250,358],"(n=348)":[251],"(odds":[252],"[OR]":[254],"5.29,":[255],"CI:":[257,362],"3.22-8.68,":[258],"P<0.0001),":[259],"irrespective":[260],"regimen.":[263],"In":[264],"total":[266],"population,":[268],"highest":[270],"rates":[272],"achieved":[274],"receiving":[279],"EDC":[280],"therapy":[281,411,443],"(47.5%":[282],"31.2%":[284],"ED;":[286],"p=NS).":[287],"(n=202)":[295],"shorter":[298],"RFS":[299,319,344],"without":[302],"(n=1,294)":[304],"(81.7%":[305],"92.2%,":[307],"HR":[308,338],"0.43,":[309,339],"0.29-0.63;":[312],"P<0.001).":[313],"Within":[314],"subgroup,":[317],"was":[320],"longer":[322],"C-containing":[325],"arm":[326,332,352],"(n=93)":[327],"control":[331],"(n=109)":[333],"(87.7%":[334],"76.6%,":[336],"respectively;":[337],"0.21-0.90;":[342],"p=0.024).":[343],"did":[345],"not":[346],"differ":[347],"among":[353],"(HR":[359],"0.74,":[360],"0.38-1.41;":[363],"p=0.357).":[364],"Conclusions:":[365],"for":[368],"promising":[373],"demonstrating":[383],"RFS,":[389],"respectively,":[390],"standard":[397],"(neo)adjuvant":[398],"regimens.":[399],"Exploratory":[400],"show":[406],"additional":[407],"TNBC,":[415],"who":[416],"typically":[418],"recognised":[419],"as":[420],"group":[422,437],"poorer":[424],"An":[426],"ongoing":[427],"conducted":[432],"by":[433],"CIBOMA":[435],"collaborative":[436],"is":[438,452],"prospectively":[439],"investigating":[440],"maintenance":[442],"after":[444],"anthracycline/taxane":[446],"TNBC.":[450],"This":[451],"first":[454],"specifically":[459],"target":[460],"interim":[466],"safety":[467],"expected":[470],"2010.":[472],"Citation":[473],"Information:":[474],"Cancer":[475],"Res":[476],"2010;70(24":[477],"Suppl):Abstract":[478],"nr":[479],"PD01-03.":[480]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}